Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Denali Therapeutics Inc’s stock clocked out at $26.34, up 2.93% from its previous closing price of $25.59. In other words, the price has increased by $2.93 from its previous closing price. On the day, 0.79 million shares were traded. DNLI stock price reached its highest trading level at $26.39 during the session, while it also had its lowest trading level at $25.34.
Ratios:
To gain a deeper understanding of DNLI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.46 and its Current Ratio is at 12.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on December 13, 2023, initiated with a Buy rating and assigned the stock a target price of $32.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when SATO VICKI L sold 3,080 shares for $25.00 per share. The transaction valued at 77,007 led to the insider holds 116,176 shares of the business.
Watts Ryan J. sold 2,260 shares of DNLI for $53,765 on Aug 20 ’24. The President and CEO now owns 235,807 shares after completing the transaction at $23.79 per share. On Aug 20 ’24, another insider, Krognes Steve E., who serves as the Director of the company, sold 1,727 shares for $23.79 each. As a result, the insider received 41,085 and left with 32,677 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 3770966016 and an Enterprise Value of 2923681024. For the stock, the TTM Price-to-Sale (P/S) ratio is 2969.16 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 2307.562 whereas that against EBITDA is -5.911.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $25.90, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is 12.92%, while the 200-Day Moving Average is calculated to be 30.34%.
Shares Statistics:
It appears that DNLI traded 1.10M shares on average per day over the past three months and 785300 shares per day over the past ten days. A total of 138.39M shares are outstanding, with a floating share count of 118.98M. Insiders hold about 16.89% of the company’s shares, while institutions hold 84.17% stake in the company. Shares short for DNLI as of 1723680000 were 8363326 with a Short Ratio of 7.60, compared to 1721001600 on 7085513. Therefore, it implies a Short% of Shares Outstanding of 8363326 and a Short% of Float of 6.84.
